רבלימיד 15 מ"ג

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

LENALIDOMIDE 15 MG

Dostopno od:

NEOPHARM SCIENTIFIC LTD

Koda artikla:

L04AX04

Farmacevtska oblika:

CAPSULES

Pot uporabe:

PER OS

Izdeluje:

CELGENE EUROPE LTD, UK

Terapevtska skupina:

LENALIDOMIDE

Terapevtske indikacije:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Datum dovoljenje:

2009-04-01